SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-005354
Filing Date
2013-09-24
Accepted
2013-09-24 17:03:08
Documents
9
Period of Report
2013-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091813_soligenix.htm 8-K 36034
2 CONTRACT STATEMENT f8k091813ex10i_soligenix.htm EX-10.1 617596
3 PRESS RELEASE f8k091813ex99i_soligenix.htm EX-99.1 18536
4 img001.jpg GRAPHIC 11884
5 img002.jpg GRAPHIC 386524
6 img003.jpg GRAPHIC 33079
7 img005.jpg GRAPHIC 12228
8 img007.jpg GRAPHIC 69613
9 img006.jpg GRAPHIC 25539
  Complete submission text file 0001213900-13-005354.txt   1416696
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 131112736
SIC: 2834 Pharmaceutical Preparations